These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 25146848)

  • 1. Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.
    Cao L; Tan L; Jiang T; Zhu XC; Yu JT
    Mol Neurobiol; 2015 Aug; 52(1):244-55. PubMed ID: 25146848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
    Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
    J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases.
    Peng J; Zeng X
    Stem Cell Res Ther; 2011 Jul; 2(4):32. PubMed ID: 21861938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in iPSC Technology in Neural Disease Modeling, Drug Screening, and Therapy.
    Dai S; Qiu L; Veeraraghavan VP; Sheu CL; Mony U
    Curr Stem Cell Res Ther; 2024; 19(6):809-819. PubMed ID: 37291782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders.
    Okano H; Morimoto S
    Cell Stem Cell; 2022 Feb; 29(2):189-208. PubMed ID: 35120619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
    Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
    Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
    Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
    Payne NL; Sylvain A; O'Brien C; Herszfeld D; Sun G; Bernard CC
    N Biotechnol; 2015 Jan; 32(1):212-28. PubMed ID: 24815224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.
    Liu L; Huang JS; Han C; Zhang GX; Xu XY; Shen Y; Li J; Jiang HY; Lin ZC; Xiong N; Wang T
    Mol Neurobiol; 2016 Dec; 53(10):6698-6708. PubMed ID: 26659595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.
    Kolagar TA; Farzaneh M; Nikkar N; Khoshnam SE
    Curr Stem Cell Res Ther; 2020; 15(2):102-110. PubMed ID: 31441732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Huntington's disease with induced pluripotent stem cells.
    Kaye JA; Finkbeiner S
    Mol Cell Neurosci; 2013 Sep; 56():50-64. PubMed ID: 23459227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases.
    Zhang X; Hu D; Shang Y; Qi X
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165431. PubMed ID: 30898538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegenerative disease-specific induced pluripotent stem cell research.
    Inoue H
    Exp Cell Res; 2010 Oct; 316(16):2560-4. PubMed ID: 20420829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Cell Models for Investigating Neurodegenerative Diseases.
    Evangelisti C; Ramadan S; Orlacchio A; Panza E
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.
    Jung YW; Hysolli E; Kim KY; Tanaka Y; Park IH
    Curr Opin Neurol; 2012 Apr; 25(2):125-30. PubMed ID: 22357218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics.
    Sen T; Thummer RP
    Neurotox Res; 2022 Oct; 40(5):1597-1623. PubMed ID: 36044181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.